Suppr超能文献

Ly-5抗体对抗体依赖性细胞介导的细胞毒性(ADCC)的影响。

Effects of Ly-5 antibodies on antibody-dependent cell-mediated cytotoxicity (ADCC).

作者信息

Small R M, Walden S M, Ewald S J

出版信息

Immunology. 1987 Feb;60(2):159-65.

Abstract

Antibodies to a number of cell surface antigens expressed on mouse spleen cells were tested for their ability to inhibit antibody-dependent cell-mediated cytotoxicity (ADCC) of antibody-coated sheep erythrocytes (Ab-SE) in the absence of complement. Of the antibodies tested, only the antisera to Ly-5 and H-2 antigens significantly inhibited ADCC by spleen cells reactive with those antisera. Inhibition by Ly-5 antisera was shown to be allotype-specific by inhibition experiments using C57BL/6-Ly-5.1 (B6-Ly-5.1) and congenic C57BL/6-Ly-5.2 (B6-Ly-5.2) mice. Inhibition by Ly-5.1 antiserum appeared not to be due to competition for the Fc receptor (FcR), since in mixing experiments 'third-party' thymus cells treated with Ly-5 antiserum did not inhibit the cytotoxic activity of untreated cells. In comparing inhibition induced by antisera to H-2 and Ly-5 antigens, Ly-5.1 antiserum was more inhibitory at nearly every dilution tested. In addition, F(ab')2 fragments of Protein A-purified Ly-5.1 antibody were inhibitory to BALB/c spleen effector cells in ADCC of Ab-SE, whereas F(ab')2 fragments of H-2 antibodies had no effect. Because ADCC of tumour cells may share a common lytic mechanism with ADCC of erythrocytes, several antisera to cell surface antigens found on spleen cells were tested for inhibition of ADCC to antibody-coated P815 tumour cells (Ab-P815). As seen in ADCC to Ab-SE, anti-Ly-5.1 was a more potent inhibitor than antibody against either H-2k or H-2d antigens. The results are discussed in the light of the ability of Ly-5 antisera to inhibit various types of cell-mediated killing.

摘要

检测了针对小鼠脾细胞上表达的多种细胞表面抗原的抗体,以评估它们在无补体情况下抑制抗体包被的绵羊红细胞(Ab-SE)的抗体依赖性细胞介导的细胞毒性(ADCC)的能力。在所检测的抗体中,只有抗Ly-5和H-2抗原的抗血清能显著抑制与这些抗血清反应的脾细胞的ADCC。通过使用C57BL/6-Ly-5.1(B6-Ly-5.1)和同基因的C57BL/6-Ly-5.2(B6-Ly-5.2)小鼠进行的抑制实验表明,Ly-5抗血清的抑制作用具有同种异型特异性。Ly-5.1抗血清的抑制作用似乎不是由于对Fc受体(FcR)的竞争,因为在混合实验中,用Ly-5抗血清处理的“第三方”胸腺细胞不会抑制未处理细胞的细胞毒性活性。在比较抗H-2和Ly-5抗原的抗血清诱导的抑制作用时,Ly-5.1抗血清在几乎所有测试的稀释度下都具有更强的抑制作用。此外,蛋白A纯化的Ly-5.1抗体的F(ab')2片段在Ab-SE的ADCC中对BALB/c脾效应细胞具有抑制作用,而H-2抗体的F(ab')2片段则没有作用。由于肿瘤细胞的ADCC可能与红细胞的ADCC具有共同的裂解机制,因此检测了几种针对脾细胞上发现的细胞表面抗原的抗血清对抗体包被的P815肿瘤细胞(Ab-P815)的ADCC的抑制作用。如在对Ab-SE的ADCC中所见,抗Ly-5.1比抗H-2k或H-2d抗原的抗体是更有效的抑制剂。根据Ly-5抗血清抑制各种类型细胞介导杀伤的能力对结果进行了讨论。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验